BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Selvaraj EA, Mózes FE, Jayaswal ANA, Zafarmand MH, Vali Y, Lee JA, Levick CK, Young LAJ, Palaniyappan N, Liu CH, Aithal GP, Romero-Gómez M, Brosnan MJ, Tuthill TA, Anstee QM, Neubauer S, Harrison SA, Bossuyt PM, Pavlides M; LITMUS Investigators. Diagnostic accuracy of elastography and magnetic resonance imaging in patients with NAFLD: A systematic review and meta-analysis. J Hepatol 2021:S0168-8278(21)00309-3. [PMID: 33991635 DOI: 10.1016/j.jhep.2021.04.044] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 4.0] [Reference Citation Analysis]
Number Citing Articles
1 Venkatesh SK, Torbenson MS. Liver fibrosis quantification. Abdom Radiol. [DOI: 10.1007/s00261-021-03396-y] [Reference Citation Analysis]
2 Lockhart ME. NASH Diagnosis Made Better but Maybe Not Yet Easier. Radiology 2021;301:635-6. [PMID: 34519579 DOI: 10.1148/radiol.2021212104] [Reference Citation Analysis]
3 Wáng YXJ, Xiao BH, Zheng CJ, Li T, Che-Nordin N, Wang W. More promising results of liver intravoxel incoherent motion imaging analysis for the assessment of nonalcoholic steatohepatitis and fibrosis. Ann Transl Med 2021;9:1283. [PMID: 34532420 DOI: 10.21037/atm-21-3442] [Reference Citation Analysis]
4 Hockings PD, Mózes FE, Pavlides M. Editorial for "Assessment of Imaging Modalities Against Liver Biopsy in Nonalcoholic Fatty Liver Disease: The Amsterdam NAFLD-NASH Cohort". J Magn Reson Imaging 2021. [PMID: 34189799 DOI: 10.1002/jmri.27808] [Reference Citation Analysis]
5 Yang S, Cheng J, Zhang R, Sun H, Zhang H, Lyu S, Duan W. Metabolic dysfunction-associated fatty liver disease and liver fibrosis: Prevalence and associated factors in the middle-aged and older US population. Hepatol Res 2021. [PMID: 34751487 DOI: 10.1111/hepr.13728] [Reference Citation Analysis]
6 Eguchi A, Iwasa M, Yamada M, Tamai Y, Shigefuku R, Hasegawa H, Hirokawa Y, Hayashi A, Okuno K, Matsushita Y, Nakatsuka T, Enooku K, Sakaguchi K, Kobayashi Y, Yamaguchi T, Watanabe M, Takei Y, Nakagawa H. A new detection system for serum fragmented cytokeratin 18 as a biomarker reflecting histologic activities of human nonalcoholic steatohepatitis. Hepatol Commun 2022. [PMID: 35485207 DOI: 10.1002/hep4.1971] [Reference Citation Analysis]
7 Sohn W, Kwon HJ, Chang Y, Ryu S, Cho YK. Liver Fibrosis in Asians With Metabolic Dysfunction-Associated Fatty Liver Disease. Clin Gastroenterol Hepatol 2021:S1542-3565(21)00706-0. [PMID: 34224877 DOI: 10.1016/j.cgh.2021.06.042] [Reference Citation Analysis]
8 Caponi S, Passeri A, Capponi G, Fioretto D, Vassalli M, Mattarelli M. Non-contact elastography methods in mechanobiology: a point of view. Eur Biophys J 2021. [PMID: 34463775 DOI: 10.1007/s00249-021-01567-9] [Reference Citation Analysis]
9 Chen SH, Lai HC, Su WP, Kao JT, Chuang PH, Hsu WF, Wang HW, Tsai TY, Chen HY, Peng CY. Liver and Spleen Stiffness Surveillance Through Elastography During and After Direct-Acting Antiviral Therapy in Patients With Chronic Hepatitis C. J Ultrasound Med 2021. [PMID: 34415630 DOI: 10.1002/jum.15806] [Reference Citation Analysis]
10 Hanniman E, Costa AF, Bowen CV, Abdolell M, Stueck A, McLeod M, Peltekian K, Rioux J, Clarke SE. Prospective Evaluation of Virtual MR Elastography With Diffusion-Weighted Imaging in Subjects With Nonalcoholic Fatty Liver Disease. J Magn Reson Imaging 2022. [PMID: 35285996 DOI: 10.1002/jmri.28154] [Reference Citation Analysis]
11 Argalia G, Ventura C, Tosi N, Campioni D, Tagliati C, Tufillaro M, Cucco M, Svegliati Baroni G, Giovagnoni A. Comparison of point shear wave elastography and transient elastography in the evaluation of patients with NAFLD. Radiol Med 2022. [PMID: 35290569 DOI: 10.1007/s11547-022-01475-8] [Reference Citation Analysis]
12 Schuppan D, Myneni S, Surabattula R. Liquid biomarkers for fibrotic NASH - progress in a complex field. J Hepatol 2022;76:5-7. [PMID: 34801249 DOI: 10.1016/j.jhep.2021.11.005] [Reference Citation Analysis]
13 Bilson J, Scorletti E, Bindels LB, Afolabi PR, Targher G, Calder PC, Sethi JK, Byrne CD. Growth differentiation factor-15 and the association between type 2 diabetes and liver fibrosis in NAFLD. Nutr Diabetes 2021;11:32. [PMID: 34663793 DOI: 10.1038/s41387-021-00170-3] [Reference Citation Analysis]
14 Dong B, Chen Y, Lyu G, Qin R. Liver stiffness measurement as a quantitative method for liver fibrosis in children with non-alcoholic fatty liver disease: A meta-analysis. J Paediatr Child Health 2021. [PMID: 34554611 DOI: 10.1111/jpc.15751] [Reference Citation Analysis]
15 Pepin KM, Welle CL, Guglielmo FF, Dillman JR, Venkatesh SK. Magnetic resonance elastography of the liver: everything you need to know to get started. Abdom Radiol (NY) 2021. [PMID: 34725719 DOI: 10.1007/s00261-021-03324-0] [Reference Citation Analysis]